These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26514196)

  • 1. Toward a Better Understanding of the Complexity of Cancer Drug Resistance.
    Gottesman MM; Lavi O; Hall MD; Gillet JP
    Annu Rev Pharmacol Toxicol; 2016; 56():85-102. PubMed ID: 26514196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to chemotherapy in cancer: a complex and integrated cellular response.
    Mellor HR; Callaghan R
    Pharmacology; 2008; 81(4):275-300. PubMed ID: 18259091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs modulate the drug response of tumor cells.
    Wu X; Xiao H
    Sci China C Life Sci; 2009 Sep; 52(9):797-801. PubMed ID: 19802736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors and drug resistance.
    Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
    Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different strategies to overcome multidrug resistance in cancer.
    Saraswathy M; Gong S
    Biotechnol Adv; 2013 Dec; 31(8):1397-407. PubMed ID: 23800690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of drug resistance in cancer chemotherapy.
    Luqmani YA
    Med Princ Pract; 2005; 14 Suppl 1():35-48. PubMed ID: 16103712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of resistance to targeted cancer therapeutics.
    Mellinghoff IK; Sawyers CL
    Pharmacogenomics; 2002 Sep; 3(5):603-23. PubMed ID: 12223047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression.
    Nobili S; Landini I; Mazzei T; Mini E
    Med Res Rev; 2012 Nov; 32(6):1220-62. PubMed ID: 21374643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cells acquire resistance to anticancer drugs: an update.
    Lu HP; Chao CC
    Biomed J; 2012; 35(6):464-72. PubMed ID: 23442359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.
    Krech T; Scheuerer E; Geffers R; Kreipe H; Lehmann U; Christgen M
    Cancer Lett; 2012 Feb; 315(2):153-60. PubMed ID: 22118813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
    Maxwell SA; Mousavi-Fard S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the Pathways of Resistance to Targeted Therapies.
    Wood KC
    Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding resistance to targeted cancer drugs through loss of function genetic screens.
    Berns K; Bernards R
    Drug Resist Updat; 2012 Oct; 15(5-6):268-75. PubMed ID: 23142522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling multi-mutation and drug resistance: analysis of some case studies.
    Feizabadi MS
    Theor Biol Med Model; 2017 Mar; 14(1):6. PubMed ID: 28327183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in cancer therapy: role of the microenvironment.
    Galmarini CM; Galmarini FC
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.